Alzumab
- Stories
Biocon’s Itolizumab, COVID-19 drug got approved by DGCA; just after 30 human trials…
Drugs Controller General of India (DCGI) approved biopharmaceuticals company Biocon’s Itolizumab (ALZUMAb) which is a plaque psoriasis drug as an…
Read More »